Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · IEX Real-Time Price · USD
20.13
+0.53 (2.70%)
At close: Jun 24, 2022 4:00 PM
20.43
+0.30 (1.49%)
After-hours:
Jun 24, 2022 6:20 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
|
Selling, General & Admin
|
36.35 | 18.23 | 7.98 | 3.77 |
|
Research & Development
|
137.02 | 62.11 | 37.16 | 17.68 |
|
Operating Expenses
|
173.36 | 80.34 | 45.14 | 21.45 |
|
Operating Income
|
-173.36 | -80.34 | -45.14 | -21.45 |
|
Interest Expense / Income
|
0.18 | 0.12 | 0.05 | 0.02 |
|
Other Expense / Income
|
-73.32 | -34.86 | -3.94 | 0 |
|
Pretax Income
|
-100.22 | -45.59 | -41.25 | -21.47 |
|
Net Income
|
-100.22 | -45.59 | -41.25 | -21.47 |
|
Preferred Dividends
|
0 | 9.05 | 0 | 0 |
|
Net Income Common
|
-100.22 | -45.59 | -41.25 | -21.47 |
|
Shares Outstanding (Basic)
|
48 | 17 | 2 | 2 |
|
Shares Outstanding (Diluted)
|
48 | 17 | 2 | 2 |
|
Shares Change
|
176.60% | 921.45% | -9.44% | - |
|
EPS (Basic)
|
-2.09 | -3.15 | -24.28 | -11.45 |
|
EPS (Diluted)
|
-2.09 | -3.15 | -24.28 | -11.45 |
|
Free Cash Flow Per Share
|
-2.72 | 4.55 | 10.23 | -10.25 |
|
EBITDA
|
-97.65 | -43.72 | -40.38 | -21.25 |
|
Depreciation & Amortization
|
2.4 | 1.76 | 0.83 | 0.21 |
|
EBIT
|
-100.04 | -45.48 | -41.2 | -21.45 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).